Weedkiller drug could help thousands who suffer from ‘black bone disease’

Sky News published this video item, entitled “Weedkiller drug could help thousands who suffer from ‘black bone disease'” – below is their description.

Final approval has been granted for a drug that treats a rare genetic condition that leads to joint pain and in some cases death.

Nitisinone has been approved for use after trials showed it can halt the progress of Alkaptonuria (AKU) , and provide hope for a pain free future for the 30,000 people who have the condition in the UK.

Julien Sireau was diagnosed with AKU 20 years ago and his family has dedicated his life to campaigning and fundraising to help find a cure.

Sky News YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - Sky News

Sky News is a British free-to-air television news channel and organisation. Sky News is distributed via a radio news service, and through online channels. It is owned by Sky Group, a division of Comcast. John Ryley is the head of Sky News, a role he has held since June 2006.

Recent from Sky News:

Us forces have conducted airstrikes against houthi anti-ship missile 1

US forces have conducted airstrikes against Houthi anti-ship missile

Lammy speech repeatedly interrupted by pro-Palestinian protesters

BREAKING: Man found dead alongside young girls and woman in Norfolk named

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.